ENTECAVIR

作品数：130被引量：879H指数：17
导出分析报告
相关领域：医药卫生更多>>
相关作者：朱映光温钦清丁莹刘萍萍廖娟更多>>
相关机构：华东师范大学北京化工大学四川大学华西医院浙江金立源药业有限公司更多>>
相关期刊：更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划广西壮族自治区自然科学基金福建省自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Histological efficacy of traditional Chinese medicine plus entecavir therapy for HBV-related liver fibrosis
《Gastroenterology & Hepatology Research》2024年第4期1-9,共9页Ting-Ting Zhu Yun-Kai Dai Xin Sun Zhi-Min Zhao Feng Xing Zheng-Xin Li Cheng-Hai Liu 
the National Natural Science Foundation of China(No.82305100,82305200,82205052)for their support.
Background/Aims:Traditional Chinese medicine(TCM)combined with antiviral therapy has been proven to be effective for liver fibrosis due to chronic hepatitis B(CHB)in clinical practice in China.However,the robust evide...
关键词：traditional Chinese medicine ENTECAVIR HBV-related fibrosis or cirrhosis meta-analysis randomized controlled trials 
Long-term efficacy and safety of tenofovir alafenamide,tenofovir disoproxil fumarate,and entecavir in treating hepatitis B virus-related acute-on-chronic liver failure:A 144-week data analysis
《Liver Research》2024年第4期295-303,共9页Yeqiong Zhang Wenxiong Xu Zhexuan Deng Lu Wang Xingrong Zheng Xiang Zhu Xuejun Li Jianguo Li Xin Shu Jing Lai Liang Peng Chan Xie 
supported by grants from Key-Area Research and Development Program of Guangdong Province(No.2020B0101130015);Guangdong Medical Science and Technology Research Fund(No.A2021304);the Natural Science Foundation of China(No.82070611);Guangzhou Science and Technology Plan Projects(No.2023B03J1287);Guangzhou Science and Technology Program Key Projects(No.2023B01J1007);Sun Yat-Sen University Clinical Research 5010 Program(No.2020007);the Five-Year Plan of Third Affiliated Hospital of Sun Yat-sen University(No.2023W106);Clinical trial number:ClinicalTrials.gov ID:NCT03920618.
Background and aims:Antiviral therapy is essential for hepatitis B virus-related acute-on-chronic liver failure(HBV-ACLF).No data are available on the long-term prognosis or safety of tenofovir alafenamide(TAF),tenofo...
关键词：Tenofovir alafenamide(TAF) Tenofovir disoproxil fumarate(TDF) Entecavir(ETV) Hepatitis B virus(HBV) Acute-on-chronic liver failure(ACLF) 
Beneficial Effects of Traditional Chinese Medicine Fuzheng Huayu on the Occurrence of Hepatocellular Carcinoma in Patients with Compensated Chronic Hepatitis B Cirrhosis Receiving Entecavir:A Multicenter Retrospective Cohort Study被引量：2
《Journal of Clinical and Translational Hepatology》2024年第5期505-515,共11页Haina Fan Shujuan Lei Zhimin Zhao Yan Huang Hui Wang Xudong Liu Xiaodong Li Min Xu Wei Zhang Kewei Sun Huichun Xing Yang Mei Jiaquan Huang Chuanwu Zhu Kejun Zhang Yali Zong Xizhong Shen Qing Xie Chenghai Liu 
supported by the Shanghai Key Specialty of Traditional Chinese Clinical Medicine(grant number shslczdzk01201);the National Science and Technology Major Project(grant number 2018ZX10302204);Shanghai University of Traditional Chinese Medicine(grant number ZYJK FW201811013).
Background and Aims:The application of antifibrotic drugs to treat patients with chronic liver diseases who are receiving antiviral therapies for hepatocellular carcinoma(HCC)has not been established.Here,we aimed to ...
关键词：ENTECAVIR Fuzheng Huayu Hepatitis B virus CIRRHOSIS Hepatocellular carcinoma Traditional Chinese Medicine 
HBsAg kinetics after 7 years of therapy with tenofovir disoproxil fumarate in a cohort of naïve patients affected by chronic hepatitis B with different genotypes
《Infectious Medicine》2024年第1期75-78,共4页Lucio Boglione Tommaso Lupia Giacomo Stroffolini Valentina Dodaro Giovanni Di Perri 
Background:The role of different genotypes in nucleos(t)ide analogs(NAs)treatment is still debated.Previous studies conducted on special populations evidenced that the E genotype had the lower virological and serologi...
关键词：Hepatitis B Tenofovir disoproxil fumarate HBsAg decline Serological response ENTECAVIR 
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients
《World Journal of Hepatology》2024年第1期109-111,共3页Yu-Tong Sun Qian-Qian Chen 
This letter comments on the article which reported that tenofovir alafenamide may increase blood lipid levels compared with entecavir in patients with chronic hepatitis B published on World J Hepatol 2023 August 27.We...
关键词：Tenofovir alafenamide ENTECAVIR Serum lipid levels Hepatitis B virus 
Efficacy and safety of tenofovir alafenamide in patients with chronic hepatitis B exhibiting suboptimal response to entecavir
《World Journal of Clinical Cases》2023年第34期8139-8146,共8页Gui-Cai Yuan Ai-Zhen Chen Wei-Xin Wang Xu-Lan Yi Long Tu Fang Peng Zhi-Hong Qiu 
Study on the efficacy and safety of tenofovir alafenamide in treating chronic hepatitis B patients with poor entecavir response,No.SKJP22020201008.
BACKGROUND Entecavir(ETV)is a potent and safe antiviral agent for patients with chronic hepatitis B(CHB);however,some patients may exhibit suboptimal response or resistance to ETV.Tenofovir alafenamide(TAF)is a novel ...
关键词：ENTECAVIR Tenofovir alafenamide Chronic hepatitis B Virologic response Renal and bone toxicity Suboptimal response 
The power of prevention:how tenofovir and entecavir are changing the game in hepatocellular carcinoma被引量：1
《Hepatobiliary Surgery and Nutrition》2023年第6期936-940,共5页Endrit Shahini Rossella Donghia Antonio Facciorusso 
Introduction Individual patient data(IPD)meta-analysis by Choi et al.(1)compared hepatocellular carcinoma(HCC)risk between the entecavir(ETV)and tenofovir(TDF)in treatment-naïve chronic hepatitis B(CHB)patients using ...
关键词：Hepatocellular carcinoma(HCC) liver cancer cirrhosis hepatitis B virus(HBV) 
Is tenofovir disoproxil fumarate superior to entecavir for prevention of hepatocellular carcinoma in patients with chronic hepatitis B?被引量：1
《Hepatobiliary Surgery and Nutrition》2023年第6期919-922,共4页Lisa M.van Velsen Milan J.Sonneveld Karel J.van Erpecum 
Chronic hepatitis B(CHB)remains a major global health problem with approximately 258 million infected individuals(1).Hepatocellular carcinoma(HCC)is one of the major and most deadly consequences of CHB.Especially cirr...
关键词：Hepatocellular carcinoma(HCC) ENTECAVIR TENOFOVIR chronic hepatitis B(CHB) 
Effects of viral load on tenofovir vs.entecavir efficacy in recurrence prevention of hepatitis B virus-related hepatocellular carcinoma
《Chinese Medical Journal》2023年第19期2362-2364,共3页Weili Qi Junyi Shen Yu Zhang Fengwei Gao Chuan Li 
supported by grants from the National Natural Science Foundation of China(Nos.81900576,82100650);the Science and Technological Supports Project of Sichuan Province(Nos.2019YJ0149,22ZDYF1593);the Post-Doctor Research Project,West China Hospital,Sichuan University(No.2020HXBH069)
Serum hepatitis B virus deoxyribonucleic acid(HBVDNA)load is a critical index used to reflect the degree of viral replication in hepatocytes and to evaluate host hepatitis viral status.The risk of hepatocellular carci...
关键词：PREVENTION HEPATOCELLULAR load 
Baseline metabolites could predict responders with hepatitis B virus-related liver fibrosis for entecavir or combined with FuzhengHuayu tablet被引量：3
《World Journal of Hepatology》2023年第9期1043-1059,共17页Yun-Kai Dai Hai-Na Fan Kai Huang Xin Sun Zhi-Min Zhao Cheng-Hai Liu 
Supported by National Science and Technology Major Project,No.2014ZX10005001 and No.2018ZX10302204;National Natural Science Foundation of China,No.81730109 and No.82274305;Shanghai Key Specialty of Traditional Chinese Clinical Medicine,No.shslczdzk01201;China Postdoctoral Science Foundation,No.2022M722162;Siming Youth Fund of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,No.SGKJ-202104.
BACKGROUND After receiving entecavir or combined with FuzhengHuayu tablet(FZHY)treatment,some sufferers with hepatitis B virus(HBV)-related liver fibrosis could achieve a histological improvement while the others may ...
关键词：Serum metabolomics Differential metabolites Therapeutic responders ENTECAVIR FuzhengHuayu tablet Hepatitis B virus-related liver fibrosis 
全选清除导出
共13页<12345678910>
检索报告 对象比较 聚类工具 使用帮助 返回顶部